Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters (2023)
Attributed to:
BPIFA1: from anti-viral peptide to immunomodulator
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v15081744
Publication URI: http://dx.doi.org/10.3390/v15081744
Type: Journal Article/Review
Parent Publication: Viruses
Issue: 8